Kinetic eGFR and Novel AKI Biomarkers to Predict Renal Recovery | Zendy

Antoine Dewitte | Zendy; Olivier Joannès-Boyau | Zendy; Carole Sidobre | Zendy; Catherine Fleureau | Zendy; MarieLise Bats | Zendy; Philippe Derache | Zendy; Sébastien Leuillet | Zendy; Jean Ripoche | Zendy; Christian Combe | Zendy; Alexandre Ouattara | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Kinetic eGFR and Novel AKI Biomarkers to Predict Renal Recovery

Author(s) -

Antoine Dewitte,

Olivier Joannès-Boyau,

Carole Sidobre,

Catherine Fleureau,

MarieLise Bats,

Philippe Derache,

Sébastien Leuillet,

Jean Ripoche,

Christian Combe,

Alexandre Ouattara

Publication year - 2015

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.12651214

Subject(s) - medicine , acute kidney injury , oliguria , creatinine , renal function , receiver operating characteristic , urology , intensive care unit , area under the curve , adverse effect , intensive care medicine

Prompt recognition of severe renal impairment could improve the early management of critically ill patients. We compared the value of kinetic eGFR, plasma neutrophil gelatinase-associated lipocalin (NGAL), and urine tissue inhibitor of metalloproteinase-2 and urine insulin-like growth factor-binding protein 7 ([TIMP-2]*[IGFBP7]) in predicting short-term recovery from AKI and major adverse kidney events.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research